| Year |
Citation |
Score |
| 2024 |
Schmierer J, Takimoto T. Functional Analysis of GRSF1 in the Nuclear Export and Translation of Influenza A Virus mRNAs. Viruses. 16. PMID 39066299 DOI: 10.3390/v16071136 |
0.383 |
|
| 2024 |
Hardy K, Lutz M, Takimoto T. Human coronavirus NL63 nsp1 induces degradation of RNA polymerase II to inhibit host protein synthesis. Plos Pathogens. 20: e1012329. PMID 38900816 DOI: 10.1371/journal.ppat.1012329 |
0.335 |
|
| 2022 |
Lutz M, Schmierer J, Takimoto T. Host adaptive mutations in the 2009 H1N1 pandemic influenza A virus PA gene regulate translation efficiency of viral mRNAs via GRSF1. Communications Biology. 5: 1102. PMID 36253464 DOI: 10.1038/s42003-022-04082-5 |
0.492 |
|
| 2021 |
Kurebayashi Y, Bajimaya S, Watanabe M, Lim N, Lutz M, Dunagan M, Takimoto T. Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells. Plos Pathogens. 17: e1009908. PMID 34529742 DOI: 10.1371/journal.ppat.1009908 |
0.385 |
|
| 2021 |
Dunagan MM, Hardy K, Takimoto T. Impact of Influenza A Virus Shutoff Proteins on Host Immune Responses. Vaccines. 9. PMID 34200539 DOI: 10.3390/vaccines9060629 |
0.425 |
|
| 2020 |
Genoyer E, Kulej K, Hung CT, Thibault PA, Azarm K, Takimoto T, Garcia BA, Lee B, Lakdawala S, Weitzman MD, López CB. The Viral Polymerase Complex Mediates the Interaction of Viral Ribonucleoprotein Complexes with Recycling Endosomes during Sendai Virus Assembly. Mbio. 11. PMID 32843550 DOI: 10.1128/Mbio.02028-20 |
0.602 |
|
| 2020 |
Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, Meagher M, Jones BG, Sealy RE, Coleclough C, Branum K, Dickey M, Buschle K, McNeal M, Makowski M, et al. Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults. Human Vaccines & Immunotherapeutics. 1-6. PMID 32750273 DOI: 10.1080/21645515.2020.1779517 |
0.45 |
|
| 2020 |
Lutz Iv MM, Dunagan MM, Kurebayashi Y, Takimoto T. Key Role of the Influenza A Virus PA Gene Segment in the Emergence of Pandemic Viruses. Viruses. 12. PMID 32224899 DOI: 10.3390/V12040365 |
0.581 |
|
| 2018 |
Chaimayo C, Dunagan M, Hayashi T, Santoso N, Takimoto T. Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity. Plos Pathogens. 14: e1007465. PMID 30496325 DOI: 10.1371/Journal.Ppat.1007465 |
0.611 |
|
| 2017 |
Bajimaya S, Frankl T, Hayashi T, Takimoto T. Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology. 510: 234-241. PMID 28750327 DOI: 10.1016/J.Virol.2017.07.024 |
0.533 |
|
| 2017 |
Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge. Virology. 509: 60-66. PMID 28605636 DOI: 10.1016/J.Virol.2017.05.021 |
0.409 |
|
| 2017 |
Bajimaya S, Hayashi T, Takimoto T. Rescue of Sendai Virus from Cloned cDNA. Methods in Molecular Biology (Clifton, N.J.). 1602: 103-110. PMID 28508216 DOI: 10.1007/978-1-4939-6964-7_7 |
0.525 |
|
| 2017 |
Chaimayo C, Hayashi T, Underwood A, Hodges E, Takimoto T. Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein. Virology. 505: 23-32. PMID 28219018 DOI: 10.1016/J.Virol.2017.02.008 |
0.582 |
|
| 2016 |
Bajimaya S, Hayashi T, Frankl T, Bryk P, Ward B, Takimoto T. Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses. Virology. 501: 127-135. PMID 27915128 DOI: 10.1016/J.Virol.2016.11.011 |
0.492 |
|
| 2016 |
Hayashi T, Chaimayo C, McGuinness J, Takimoto T. Critical role of the PA-X C-terminal domain of influenza A virus on its subcellular localization and shutoff activity. Journal of Virology. PMID 27226377 DOI: 10.1128/Jvi.00954-16 |
0.421 |
|
| 2015 |
Stone R, Hayashi T, Bajimaya S, Hodges E, Takimoto T. Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses. Virology. 487: 11-18. PMID 26484934 DOI: 10.1016/J.Virol.2015.10.008 |
0.573 |
|
| 2015 |
Hayashi T, Chaimayo C, Takimoto T. Impact of influenza PA-X on host response. Oncotarget. 6: 19364-5. PMID 26305985 DOI: 10.18632/Oncotarget.5127 |
0.623 |
|
| 2015 |
Hayashi T, Wills S, Bussey KA, Takimoto T. Identification of influenza A virus PB2 Residues involved in enhanced polymerase activity and virus growth in mammalian cells at low temperatures Journal of Virology. 89: 8042-8049. PMID 26018156 DOI: 10.1128/Jvi.00901-15 |
0.843 |
|
| 2015 |
Fukushima K, Takahashi T, Ueyama H, Takaguchi M, Ito S, Oishi K, Minami A, Ishitsubo E, Tokiwa H, Takimoto T, Suzuki T. Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase. Febs Letters. 589: 1278-82. PMID 25871520 DOI: 10.1016/J.Febslet.2015.03.036 |
0.401 |
|
| 2015 |
Hayashi T, MacDonald LA, Takimoto T. Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses. Journal of Virology. 89: 6442-52. PMID 25855745 DOI: 10.1128/Jvi.00319-15 |
0.631 |
|
| 2015 |
Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats. International Immunology. 27: 229-36. PMID 25477211 DOI: 10.1093/Intimm/Dxu107 |
0.498 |
|
| 2014 |
Fukushima K, Takahashi T, Ito S, Takaguchi M, Takano M, Kurebayashi Y, Oishi K, Minami A, Kato T, Park EY, Nishimura H, Takimoto T, Suzuki T. Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3. Virology. 464: 424-31. PMID 25146600 DOI: 10.1016/J.Virol.2014.07.033 |
0.362 |
|
| 2014 |
Bialas KM, Bussey KA, Stone RL, Takimoto T. Specific nucleoprotein residues affect influenza virus morphology. Journal of Virology. 88: 2227-34. PMID 24335312 DOI: 10.1128/Jvi.03354-13 |
0.789 |
|
| 2013 |
Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T, Kawaoka Y. A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine. Vaccine. 31: 6239-46. PMID 24144478 DOI: 10.1016/J.Vaccine.2013.10.029 |
0.585 |
|
| 2013 |
Stone R, Takimoto T. Critical role of the fusion protein cytoplasmic tail sequence in parainfluenza virus assembly. Plos One. 8: e61281. PMID 23593451 DOI: 10.1371/Journal.Pone.0061281 |
0.504 |
|
| 2013 |
Fouchier RA, GarcÃa-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, ... ... Takimoto T, et al. Transmission studies resume for avian flu. Science (New York, N.Y.). 339: 520-1. PMID 23345603 DOI: 10.1126/Science.1235140 |
0.465 |
|
| 2013 |
Desmet EA, Bussey KA, Stone R, Takimoto T. Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis. Journal of Virology. 87: 3108-18. PMID 23283952 DOI: 10.1128/Jvi.02826-12 |
0.783 |
|
| 2012 |
Bialas KM, Desmet EA, Takimoto T. Specific residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro. Plos One. 7: e50595. PMID 23209789 DOI: 10.1371/Journal.Pone.0050595 |
0.793 |
|
| 2012 |
Noronha JM, Liu M, Squires RB, Pickett BE, Hale BG, Air GM, Galloway SE, Takimoto T, Schmolke M, Hunt V, Klem E, García-Sastre A, McGee M, Scheuermann RH. Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction. Journal of Virology. 86: 5857-66. PMID 22398283 DOI: 10.1128/Jvi.06901-11 |
0.598 |
|
| 2012 |
MacDonald LA, Aggarwal S, Bussey KA, Desmet EA, Kim B, Takimoto T. Molecular interactions and trafficking of influenza A virus polymerase proteins analyzed by specific monoclonal antibodies. Virology. 426: 51-9. PMID 22325937 DOI: 10.1016/J.Virol.2012.01.015 |
0.773 |
|
| 2012 |
Fouchier RA, GarcÃa-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, ... ... Takimoto T, et al. Pause on avian flu transmission research. Science (New York, N.Y.). 335: 400-1. PMID 22282787 DOI: 10.1126/science.335.6067.400 |
0.554 |
|
| 2012 |
Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection Vaccine. 30: 959-968. PMID 22119594 DOI: 10.1016/J.Vaccine.2011.11.046 |
0.403 |
|
| 2011 |
Aggarwal S, Dewhurst S, Takimoto T, Kim B. Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex. The Journal of Biological Chemistry. 286: 34504-13. PMID 21816827 DOI: 10.1074/Jbc.M111.262048 |
0.505 |
|
| 2011 |
Fukushima K, Takahashi T, Takaguchi M, Ueyama H, Ito S, Kurebayashi Y, Kawanishi T, McKimm-Breschkin JL, Takimoto T, Minami A, Suzuki T. Plaque formation assay for human parainfluenza virus type 1. Biological & Pharmaceutical Bulletin. 34: 996-1000. PMID 21720003 DOI: 10.1248/Bpb.34.996 |
0.468 |
|
| 2011 |
Bussey KA, Desmet EA, Mattiacio JL, Hamilton A, Bradel-Tretheway B, Bussey HE, Kim B, Dewhurst S, Takimoto T. PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells. Journal of Virology. 85: 7020-8. PMID 21561908 DOI: 10.1128/Jvi.00522-11 |
0.811 |
|
| 2011 |
Noble E, Mathews DH, Chen JL, Turner DH, Takimoto T, Kim B. Biophysical analysis of influenza A virus RNA promoter at physiological temperatures. The Journal of Biological Chemistry. 286: 22965-70. PMID 21555520 DOI: 10.1074/Jbc.M111.239509 |
0.397 |
|
| 2011 |
Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. Journal of Virology. 85: 448-55. PMID 20980523 DOI: 10.1128/Jvi.01812-10 |
0.598 |
|
| 2010 |
Chambers R, Takimoto T. Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles. Plos One. 5: e10994. PMID 20543880 DOI: 10.1371/Journal.Pone.0010994 |
0.785 |
|
| 2010 |
Aggarwal S, Bradel-Tretheway B, Takimoto T, Dewhurst S, Kim B. Biochemical characterization of enzyme fidelity of influenza A virus RNA polymerase complex. Plos One. 5: e10372. PMID 20454455 DOI: 10.1371/Journal.Pone.0010372 |
0.484 |
|
| 2010 |
Desmet EA, Hollenbaugh JA, Sime PJ, Wright TW, Topham DJ, Sant AJ, Takimoto T, Dewhurst S, Maggirwar SB. Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells. Virology. 400: 224-32. PMID 20185156 DOI: 10.1016/J.Virol.2010.02.001 |
0.823 |
|
| 2010 |
Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T. PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. Journal of Virology. 84: 4395-406. PMID 20181719 DOI: 10.1128/Jvi.02642-09 |
0.807 |
|
| 2009 |
Chambers R, Takimoto T. Antagonism of innate immunity by paramyxovirus accessory proteins. Viruses. 1: 574-93. PMID 21994561 DOI: 10.3390/V1030574 |
0.798 |
|
| 2009 |
Chambers R, Takimoto T. Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. The Journal of General Virology. 90: 1906-15. PMID 19423549 DOI: 10.1099/Vir.0.011700-0 |
0.801 |
|
| 2008 |
Bradel-Tretheway BG, Kelley Z, Chakraborty-Sett S, Takimoto T, Kim B, Dewhurst S. The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit. The Journal of General Virology. 89: 2923-32. PMID 19008377 DOI: 10.1099/Vir.0.2008/006254-0 |
0.528 |
|
| 2008 |
Zhan X, Slobod KS, Krishnamurthy S, Luque LE, Takimoto T, Jones B, Surman S, Russell CJ, Portner A, Hurwitz JL. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine. 26: 3480-8. PMID 18499307 DOI: 10.1016/J.Vaccine.2008.04.022 |
0.411 |
|
| 2007 |
Zhan X, Hurwitz JL, Krishnamurthy S, Takimoto T, Boyd K, Scroggs RA, Surman S, Portner A, Slobod KS. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine. 25: 8782-93. PMID 18037543 DOI: 10.1016/J.Vaccine.2007.10.038 |
0.449 |
|
| 2007 |
Brown SA, Hurwitz JL, Zirkel A, Surman S, Takimoto T, Alymova I, Coleclough C, Portner A, Doherty PC, Slobod KS. A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology. 81: 12535-42. PMID 17652379 DOI: 10.1128/Jvi.00197-07 |
0.438 |
|
| 2006 |
Bousse T, Takimoto T. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. Journal of Virology. 80: 9009-16. PMID 16940513 DOI: 10.1128/Jvi.00969-06 |
0.553 |
|
| 2006 |
Krishnamurthy S, Takimoto T, Scroggs RA, Portner A. Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. Journal of Virology. 80: 5145-55. PMID 16698995 DOI: 10.1128/Jvi.02618-05 |
0.389 |
|
| 2006 |
Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Research. 121: 23-32. PMID 16677733 DOI: 10.1016/J.Virusres.2006.03.012 |
0.811 |
|
| 2005 |
Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS. Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunology. 18: 255-66. PMID 16035938 DOI: 10.1089/Vim.2005.18.255 |
0.508 |
|
| 2005 |
Alymova IV, Portner A, Takimoto T, Boyd KL, Babu YS, McCullers JA. The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 49: 398-405. PMID 15616320 DOI: 10.1128/Aac.49.1.398-405.2005 |
0.463 |
|
| 2004 |
Takimoto T, Portner A. Molecular mechanism of paramyxovirus budding. Virus Research. 106: 133-45. PMID 15567493 DOI: 10.1016/J.Virusres.2004.08.010 |
0.495 |
|
| 2004 |
Bousse TL, Taylor G, Krishnamurthy S, Portner A, Samal SK, Takimoto T. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. Journal of Virology. 78: 13351-5. PMID 15542686 DOI: 10.1128/Jvi.78.23.13351-13355.2004 |
0.538 |
|
| 2004 |
Takimoto T, Hurwitz JL, Coleclough C, Prouser C, Krishnamurthy S, Zhan X, Boyd K, Scroggs RA, Brown B, Nagai Y, Portner A, Slobod KS. Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. Journal of Virology. 78: 6043-7. PMID 15141002 DOI: 10.1128/Jvi.78.11.6043-6047.2004 |
0.462 |
|
| 2004 |
Alymova IV, Taylor G, Takimoto T, Lin TH, Chand P, Babu YS, Li C, Xiong X, Portner A. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 48: 1495-502. PMID 15105096 DOI: 10.1128/Aac.48.5.1495-1502.2004 |
0.598 |
|
| 2004 |
Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, Portner A, Taylor G. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. Journal of Virology. 78: 3733-41. PMID 15016893 DOI: 10.1128/Jvi.78.7.3733-3741.2004 |
0.496 |
|
| 2002 |
Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion Journal of Virology. 76: 13028-13033. PMID 12438628 DOI: 10.1128/Jvi.76.24.13028-13033.2002 |
0.524 |
|
| 2002 |
Bousse T, Matrosovich T, Portner A, Kato A, Nagai Y, Takimoto T. The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction. Journal of Virology. 76: 8244-51. PMID 12134030 DOI: 10.1128/Jvi.76.16.8244-8251.2002 |
0.404 |
|
| 2002 |
Connaris H, Takimoto T, Russell R, Crennell S, Moustafa I, Portner A, Taylor G. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. Journal of Virology. 76: 1816-24. PMID 11799177 DOI: 10.1128/Jvi.76.4.1816-1824.2002 |
0.431 |
|
| 2001 |
Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. Role of matrix and fusion proteins in budding of Sendai virus. Journal of Virology. 75: 11384-91. PMID 11689619 DOI: 10.1128/Jvi.75.23.11384-11391.2001 |
0.466 |
|
| 2001 |
Bousse T, Takimoto T, Matrosovich T, Portner A. Two regions of the P protein are required to be active with the L protein for human parainfluenza virus type 1 RNA polymerase activity. Virology. 283: 306-14. PMID 11336555 DOI: 10.1006/Viro.2001.0881 |
0.366 |
|
| 2001 |
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, Suzuki Y, Takimoto T. Receptor specificities of human respiroviruses. Journal of Virology. 75: 4604-13. PMID 11312330 DOI: 10.1128/Jvi.75.10.4604-4613.2001 |
0.47 |
|
| 2001 |
Coronel EC, Takimoto T, Murti KG, Varich N, Portner A. Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. Journal of Virology. 75: 1117-23. PMID 11152484 DOI: 10.1128/Jvi.75.3.1117-1123.2001 |
0.454 |
|
| 2001 |
Takimoto T, Bousse T, Portner A. Molecular cloning and expression of human parainfluenza virus type 1 L gene. Virus Research. 70: 45-53. PMID 11074124 DOI: 10.1016/S0168-1702(00)00207-0 |
0.411 |
|
| 2000 |
Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nature Structural Biology. 7: 1068-74. PMID 11062565 DOI: 10.1038/81002 |
0.411 |
|
| 2000 |
Takimoto T, Taylor GL, Crennell SJ, Scroggs RA, Portner A. Crystallization of newcastle disease virus hemagglutinin-neuraminidase glycoprotein Virology. 270: 208-214. PMID 10772993 DOI: 10.1006/Viro.2000.0263 |
0.383 |
|
| 2000 |
Chen Y, Takimoto T, Liu L, Surman S, Woodland DL. DNA vaccination as a tool to identify subdominant CD8 T cell epitopes. Vaccine. 18: 720-7. PMID 10547432 DOI: 10.1016/S0264-410X(99)00265-0 |
0.421 |
|
| 1999 |
Coronel EC, Murti KG, Takimoto T, Portner A. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. Journal of Virology. 73: 7035-8. PMID 10400805 DOI: 10.1128/Jvi.73.8.7035-7038.1999 |
0.525 |
|
| 1998 |
Takimoto T, Bousse T, Coronel EC, Scroggs RA, Portner A. Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. Journal of Virology. 72: 9747-54. PMID 9811709 DOI: 10.1128/Jvi.72.12.9747-9754.1998 |
0.626 |
|
| 1997 |
Bousse T, Takimoto T, Murti KG, Portner A. Elevated expression of the human parainfluenza virus type 1 F gene downregulates HN expression. Virology. 232: 44-52. PMID 9185587 DOI: 10.1006/Viro.1997.8524 |
0.442 |
|
| 1996 |
Crennell SJ, Portner A, Takimoto T, Laver WG, Taylor GL. Towards the structure of hemagglutinin-neuraminidase from Newcastle disease virus Acta Crystallographica Section a Foundations of Crystallography. 52: C120-C121. DOI: 10.1107/S0108767396094354 |
0.495 |
|
| 1995 |
Bousse T, Takimoto T, Portner A. A single amino acid changes enhances the fusion promotion activity of human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Virology. 209: 654-7. PMID 7778298 DOI: 10.1006/Viro.1995.1299 |
0.579 |
|
| 1994 |
Hyland L, Hou S, Coleclough C, Takimoto T, Doherty PC. Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection Virology. 204: 234-241. PMID 8091654 DOI: 10.1006/Viro.1994.1527 |
0.483 |
|
| 1994 |
Takimoto T, Portner A. The human parainfluenza virus type-1 prototypic strain contains a heat-labile hemagglutinin-neuraminidase protein. Virus Research. 32: 85-92. PMID 8030367 DOI: 10.1016/0168-1702(94)90063-9 |
0.562 |
|
| 1994 |
Bousse T, Takimoto T, Gorman WL, Takahashi T, Portner A. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology. 204: 506-14. PMID 7941317 DOI: 10.1006/Viro.1994.1564 |
0.546 |
|
| 1994 |
Dave VP, Allan JE, Slobod KS, Smith FS, Ryan KW, Takimoto T, Power UF, Portner A, Hurwitz JL. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Virology. 199: 376-83. PMID 7510085 DOI: 10.1006/VIRO.1994.1135 |
0.497 |
|
| 1993 |
Murti KG, Takimoto T, Laver WG, Portner A. Crystals of hemagglutinin-neuraminidase of parainfluenza virus contain triple-stranded helices. Proceedings of the National Academy of Sciences of the United States of America. 90: 1523-5. PMID 8381970 DOI: 10.1073/Pnas.90.4.1523 |
0.412 |
|
| 1992 |
Takimoto T, Laver WG, Murti KG, Portner A. Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1. Journal of Virology. 66: 7597-600. PMID 1279210 DOI: 10.1128/Jvi.66.12.7597-7600.1992 |
0.463 |
|
| 1989 |
Sato H, Takimoto T, Tanaka S, Ogura H, Shiraishi K, Tanaka J. Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells. Journal of Virology. 63: 3555-9. PMID 2545926 DOI: 10.1128/JVI.63.8.3555-3559.1989 |
0.454 |
|
| 1989 |
Sato H, Takimoto T, Hatano M, Pagano JS, Raab-Traub N. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: Mapping of the viral genome Journal of General Virology. 70: 717-727. PMID 2543756 DOI: 10.1099/0022-1317-70-3-717 |
0.336 |
|
| Show low-probability matches. |